13F

Stock

Crispr Therapeutics Ag

CRSP · held by 18 managers

Reported value

$196.3M

Holders

18

+2 new · −0 exited

Holders’ est. mark

$6.33M

Price effect on 8 books still in the name

Largest holder

$90.6M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY1.4M$90.6MHeld
BANK OF AMERICA CORP /DE/1.12M$72.9MHeld
BARCLAYS PLC349.9K$22.7M$5.66MAdded$4.16M
NWAM LLC101.8K$7.53M$324.4KAdded$6.5M
Sanctuary Advisors, LLC9.66K$626K$147KAdded$183.8K
Allworth Financial LP9.3K$602.8KHeld
Norris Financial Group, LLC7.95K$515.5K$128.6KAdded$42.5K
INDEPENDENT FINANCIAL GROUP, LLC5K$324K$73.3KAdded$103.3K
Cresset Asset Management, LLC4.1K$265.5KNew
Swiss Life Asset Management Ltd3.76K$243.8KNew
IFP Advisors, Inc962$62.3KHeld
AllSquare Wealth Management LLC253$16.4KHeld
Medallion Wealth Advisors, LLC124$8.04K$2.02KAdded$2.02K
Essential Partners LLC72$4.67K$1.15KAdded$1.21K
MV CAPITAL MANAGEMENT, INC.37$2.4KHeld
Kilter Group LLC8$519Held
Nalls Sherbakoff Group, LLC3$194$48Added$48
KBC Group NV2.22K$144Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.